Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals

被引：11

作者：

Krestova, Michala ^{[1
,2
]}

Hromadkova, Lenka ^{[1
,3
,4
]}

Bilkova, Zuzana ^{[4
]}

Bartos, Ales ^{[1
,2
]}

Ricny, Jan ^{[1
]}

机构：

[1] Natl Inst Mental Hlth, Klecany, Czech Republic

[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic

[3] Charles Univ Prague, Fac Sci, Prague, Czech Republic

[4] Univ Pardubice, Dept Biol & Biochem Sci, Pardubice, Czech Republic

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2017年 / 313卷

关键词：

Alzheimer's disease; Brain homogenates; Plasma antibodies; Reactivity profile; Tau protein; INTRAVENOUS IMMUNOGLOBULIN PRODUCTS; NATURALLY-OCCURRING AUTOANTIBODIES; NEUROFIBRILLARY TANGLES; NEURONAL-ACTIVITY; PATHOLOGICAL TAU; ENDOGENOUS TAU; AMYLOID-BETA; A-BETA; IMMUNOTHERAPY; PROTEIN;

D O I：

10.1016/j.jneuroim.2017.09.011

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The presence of natural tau-reactive antibodies was reported in human blood. In this study, we isolated and characterized natural tau-reactive antibodies occurring in IVIG product Flebogamma, plasma of patients with Alzheimer's disease (AD) and older cognitively normal persons (controls). Using blotting immunoassays and ELISA, we showed reactivity of antibodies obtained from IVIG and controls against a recombinant fragment of tau (155-421 aa) and aggregates present in brains of AD patients. In contrast, antibodies isolated from plasma of AD patients reacted mainly with the recombinant full-length tau form and tau monomeric forms in brain tissue.

引用

页码：16 / 24

页数：9

共 50 条

[21] Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative [J].

Zettergren, Anna ;

Lord, Jodie ;

Ashton, Nicholas J. ;

Benedet, Andrea L. ;

Karikari, Thomas K. ;

Rodriguez, Juan Lantero ;

Snellman, Anniina ;

Suarez-Calvet, Marc ;

Proitsi, Petroula ;

Zetterberg, Henrik ;

Blennow, Kaj .

ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)

[22] Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia [J].

Gonzalez, Christopher ;

Tommasi, Nicole S. ;

Briggs, Danielle ;

Properzi, Michael J. ;

Amariglio, Rebecca E. ;

Marshall, Gad A. .

JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (03) :1133-1142

[23] Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment,and Alzheimer's disease dementia [J].

Banning, Leonie C. P. ;

Ramakers, Inez H. G. B. ;

Rosenberg, Paul B. ;

Lyketsos, Constantine G. ;

Leoutsakos, Jeannie-Marie S. .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 36 (01) :224-234

[24] Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer's disease [J].

Bryan III, Miles R. ;

Tian, Xu ;

Tseng, Jui-Heng ;

Evangelista, Baggio A. ;

Ragusa, Joey V. ;

Bryan, Audra F. ;

Trotman, Winifred ;

Irwin, David ;

Cohen, Todd J. .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01)

[25] Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals [J].

Pettigrew, Corinne ;

Soldan, Anja ;

Zhu, Yuxin ;

Cai, Qing ;

Wang, Mei-Cheng ;

Moghekar, Abhay ;

Miller, Michael, I ;

Singh, Baljeet ;

Martinez, Oliver ;

Fletcher, Evan ;

DeCarli, Charles ;

Albert, Marilyn .

NEUROBIOLOGY OF AGING, 2020, 88 :33-41

[26] Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals [J].

Heeman, Fiona ;

Visser, Denise ;

Yaqub, Maqsood ;

Verfaillie, Sander ;

Timmers, Tessa ;

Pijnenburg, Yolande A. L. ;

van der Flier, Wiesje M. ;

van Berckel, Bart N. M. ;

Boellaard, Ronald ;

Lammertsma, Adriaan A. ;

Golla, Sandeep S., V .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2023, 43 (03) :369-378

[27] Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease [J].

Nakano, H ;

Kobayashi, K ;

Sugimori, K ;

Shimazaki, M ;

Miyazu, K ;

Hayashi, M ;

Furuta, H .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) :122-131

[28] Cerebrospinal fluid from Alzheimer's disease patients promotes tau aggregation in transgenic mice [J].

Skachokova, Zhiva ;

Martinisi, Alfonso ;

Flach, Martin ;

Sprenger, Frederik ;

Naegelin, Yvonne ;

Steiner-Monard, Viviane ;

Sollberger, Marc ;

Monsch, Andreas U. ;

Goedert, Michel ;

Tolnay, Markus ;

Winkler, David T. .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 :72

[29] Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals [J].

Sun, Qingling ;

Ni, Jingnian ;

Wei, Mingqing ;

Long, Siwei ;

Li, Ting ;

Fan, Dongsheng ;

Lu, Tao ;

Shi, Jing ;

Tian, Jinzhou .

FRONTIERS IN AGING NEUROSCIENCE, 2022, 14

[30] Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by XanamemT Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals [J].

Villemagne, Victor L. ;

Dore, Vincent ;

Chong, Lee ;

Kassiou, Michael ;

Mulligan, Rachel ;

Feizpour, Azadeh ;

Taylor, Jack ;

Roesner, Miriam ;

Miller, Tamara ;

Rowe, Christopher C. .

JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (03) :1463-1475

← 1 2 3 4 5 →